Advertisement

Topics

Safety and Efficacy of Juvederm® VOLUMA™ for Correction of Mid-face Volume Deficiency

2010-07-15 17:00:00 | BioPortfolio

Summary

This is a prospective, open-label experience study to be conducted at 6 clinical sites in Australia, with the objective to collect efficacy and safety information for Juvederm® VOLUMA™ when used for volumising the mid-face and cheek area.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Mid-face Volume Deficiency

Intervention

Juvederm® VOLUMA™

Location

Sydney
Australia

Status

Active, not recruiting

Source

Allergan Medical

Results (where available)

View Results

Links

Published on BioPortfolio: 2010-07-15T17:00:00-0400

Clinical Trials [1098 Associated Clinical Trials listed on BioPortfolio]

Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume

The purpose of this study is to determine whether Neuramis® Volume Lidocaine is effective in the temporary restoring the mid-face volume.

A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula

The objective of this study is to evaluate the safety and effectiveness of JUVÉDERM VOLUMA XC (hereafter VOLUMA XC) injectable gel using cannula in subjects seeking correction of age-rela...

Safety and Effectiveness of Juvéderm® VOLUMA XC Injectable Gel for Cheek Augmentation

Multicenter, single-blind, randomized, "no-treatment" control study to demonstrate the safety and effectiveness of VOLUMA XC for deep injection for cheek augmentation to correct age-relate...

Safety and Effectiveness of VOLUMA With Lidocaine for Improvement of Volume and Aesthetic Appearance of the Nose in Chinese Adults.

The purpose of this study is to determine whether VOLUMA with Lidocaine is safe and effective for the improvement of volume and aesthetic appearance of the nose in the Chinese population.

Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline Contour

This study has been designed to evaluate the safety and effectiveness of sequential treatment with BELKYRA® (for the treatment of convexity and fullness associated with submental fat) and ...

PubMed Articles [6921 Associated PubMed Articles listed on BioPortfolio]

Neurobiological correlates of emotional intelligence in voice and face perception networks.

Facial expressions and voice modulations are among the most important communicational signals to convey emotional information. The ability to correctly interpret this information is highly relevant fo...

Halos and Asymmetric Triangles: Designing the Eyelids with Volume Using Fillers and/or Fat.

Periorbital aging is mainly a product of volume loss, which can be addressed with fillers and/or fat grafting. This stands in contrast to the lower face where a lifting procedure can be the principal ...

Spatial attention modulates the temporal sequence of hemispheric asymmetry in configural and featural face processing.

Face recognition requires both configural and featural processing. Configural face processing is more dependent on the right hemisphere, whereas featural face processing is more dependent on the left ...

Trismus in Face Transplantation Following Ballistic Trauma.

Trismus can be a challenging consequence of ballistic trauma to the face, and has rarely been described in the setting of face transplantation. Almost half of all current face transplant recipients in...

Fat Grafting Volume Restoration to the Brow and Temporal Regions.

Primary manifestations of facial aging are the reduction in subcutaneous tissue volume, especially the atrophy of fat as well as bone volume depletion which directly contribute to loss of support and ...

Medical and Biotech [MESH] Definitions

The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat).

The volume of air contained in the lungs at the end of a maximal inspiration. It is the equivalent to each of the following sums: VITAL CAPACITY plus RESIDUAL VOLUME; INSPIRATORY CAPACITY plus FUNCTIONAL RESIDUAL CAPACITY; TIDAL VOLUME plus INSPIRATORY RESERVE VOLUME plus functional residual capacity; or tidal volume plus inspiratory reserve volume plus EXPIRATORY RESERVE VOLUME plus residual volume.

A nutritional condition produced by a deficiency of proteins in the diet, characterized by adaptive enzyme changes in the liver, increase in amino acid synthetases, and diminution of urea formation, thus conserving nitrogen and reducing its loss in the urine. Growth, immune response, repair, and production of enzymes and hormones are all impaired in severe protein deficiency. Protein deficiency may also arise in the face of adequate protein intake if the protein is of poor quality (i.e., the content of one or more amino acids is inadequate and thus becomes the limiting factor in protein utilization). (From Merck Manual, 16th ed; Harrison's Principles of Internal Medicine, 12th ed, p406)

The volume of the HEART, usually relating to the volume of BLOOD contained within it at various periods of the cardiac cycle. The amount of blood ejected from a ventricle at each beat is STROKE VOLUME.

Volume of circulating BLOOD. It is the sum of the PLASMA VOLUME and ERYTHROCYTE VOLUME.

More From BioPortfolio on "Safety and Efficacy of Juvederm® VOLUMA™ for Correction of Mid-face Volume Deficiency"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial